KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to 0.66.

  • Chemed's Equity Ratio fell 504.76% to 0.66 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.66, marking a year-over-year decrease of 504.76%. This contributed to the annual value of 0.67 for FY2024, which is 97.44% up from last year.
  • Chemed's Equity Ratio amounted to 0.66 in Q3 2025, which was down 504.76% from 0.7 recorded in Q2 2025.
  • In the past 5 years, Chemed's Equity Ratio registered a high of 0.7 during Q3 2024, and its lowest value of 0.46 during Q4 2021.
  • For the 5-year period, Chemed's Equity Ratio averaged around 0.62, with its median value being 0.64 (2021).
  • Its Equity Ratio has fluctuated over the past 5 years, first tumbled by 2609.13% in 2021, then surged by 2266.23% in 2023.
  • Over the past 5 years, Chemed's Equity Ratio (Quarter) stood at 0.46 in 2021, then rose by 19.32% to 0.55 in 2022, then increased by 19.91% to 0.66 in 2023, then grew by 0.97% to 0.67 in 2024, then dropped by 1.12% to 0.66 in 2025.
  • Its Equity Ratio was 0.66 in Q3 2025, compared to 0.7 in Q2 2025 and 0.68 in Q1 2025.